Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression

Carcinogenesis

Volumn 29, Issue 8, 2008, Pages 1572-1580

  Čačev, Tamara ^a   Radošević, Senka ^b   Križanac, Šimun ^c   Kapitanović, Sanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

^c University of Zagreb School of Medicine   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL STRAIN HT29; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIFFERENTIATION;

COLONIC NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 49649127459     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn164     Document Type: Article

References (49)

1. Ries,L.A.G., Melbert,D., Krapcho,M., Stinchcomb,D.G., Howlader,N., Horner,M.J., Mariotto,A., Miller,B.A., Feuer,E.J., Altekruse,S.F., Lewis,D.R., Clegg,L., Eisner,M.P., Reichman,M. and Edwards,B.K. (eds.) (2007) SEER Cancer Statistics Review, 1975-2005. National Cancer Institute, Bethesda, MD.
2. Vogelstein,B. et al. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799.
3. Suh,Y. et al. (2005) SNP discovery in associating genetic variation with human disease phenotypes. Mutat. Res., 573, 41-53.
4. Dranoff,G. (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer, 4, 11-22.
5. Xie,K. (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev., 12, 375-391.
6. Mocellin,S. et al. (2005) Interleukin-10 and the immune response against cancer: A counterpoint. J. Leuko. Biol., 78, 1043-1051.
7. Huang,S. et al. (1996) Interleukin 10 suppresses tumour growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis. Clin. Cancer Res., 2, 1969-1979.
8. Howell,W.M. et al. (2007) Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J. Nutr., 137, 194-199.
9. De Vita,F. et al. (1999) Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer, 86, 1936-1943.
10. Uehara,H. et al. (2005) Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate, 64, 40-49.
11. Lee,K.H. et al. (2004) Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Oncology, 66 210-217.
12. Chung,Y.C. et al. (2003) Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology, 50, 1910-1913.
13. Asadullah,K. et al. (2003) Interleukin-10 therapy-review of a new approach. Pharmacol. Rev., 55, 241-269.
14. Haukim,N. et al. (2002) Cytokine gene polymorphism in human disease: On-line databases. Genes Immun., 3 (suppl. 2), 313-330.
15. Mukida,N. et al. (1989) Gene structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol., 143, 1366-1371.
16. Hull,J. et al. (2000) Association of respiratory syncytial virus bronchioloitis with the interleukin 8 gene region in UK families. Thorax, 55, 1023-1027.
17. Spits,H. et al. (1992) Functional characterization of human IL-10. Int. Arch. Allergy Appl. Immunol., 99, 8-15.
18. Eskdale,J. et al. (1997) Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics, 46, 120-128.
19. Turner,D.M. et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet., 24, 1-8.
20. Hurme,M. et al. (1998) Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann. Med., 30, 469-473.
21. Crawley,E. et al. (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum., 42, 1101-1108.
22. Landi,S. et al. (2003) Association of common polymorphisms in inflammatory genes IL6, IL8, TNFalpha, NFkB1 and PPAR gamma with colorectal cancer. Cancer Res., 63, 3560-3566.
23. Theodoropoulos,G. et al. (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J. Gastroenterol., 12, 5037-5043.
24. Hollegaard,M.V. et al. (2006) Cytokine gene polymorphism in human disease: On-line database. Genes Immun., 7 (suppl. 3), 269-276.
25. Friedl,P. et al. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer, 3, 362-374.
26. Luca,M. et al. (1997) Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol., 151, 1105-1113.
27. Reiland,J. et al. (1999) CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate, 41, 78-88.
28. Kundu,N. et al. (1996) Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl Cancer Inst., 88, 536-541.
29. Huang,S. et al. (1999) Regulation of tumor growth and metastasis by interleukin-10: The melanoma experience. J. Interferon Cytokine Res., 19, 697-703.
30. Spaventi,R. et al. (1994) Human tumour bank in Croatia: A possible model for a small bank as a part of future European tumour bank network. Eur. J. Cancer, 30A, 419.
31. Cacev,T. et al. (2005) NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut, 54, 1129-1135.
32. Shu,Q. et al. (2003) IL-10 polymorphism is associated with incidence of severe sepsis. Chin. Med. J., 116, 1756-1759.
33. Green,A.R. et al. (1997) Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours. Int. J. Cancer, 72, 937-941.
34. Kitadai,Y. et al. (1998) Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol., 152, 93-100.
35. Veltri,R.W. et al. (1999) Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology, 53, 139-147.
36. Sugiyama,Y. et al. (2005) Analysis of differential gene expression patterns in colorectal cancer and cancer stroma using microdissected tissues. Gastroenterology, 128, 480-486.
37. Bellone,G. et al. (2006) Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: Implications for survival. Cancer Immunol. Immunother., 55, 684-698.
38. Mustea,A. et al. (2006) Expression of IL-10 in patients with ovarian carcinoma. Anticancer Res., 26, 1715-1718.
39. Mocellin,S. et al. (2001) Cytokines and immune response in the tumor microenvironment. J. Immunother., 24, 392-407.
40. Uwatoko,N. et al. (2002) Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma. Int. J. Oncol., 20, 729-733.
41. Nemunaitis,J. et al. (2001) Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer Invest., 19, 239-247.
42. Autschbach,F. et al. (1998) In situ expression of interleukin-10 in noninflamed human gut and inflammatory bowel disease. Am. J. Pathol., 153, 121-130.
43. MacArthur,M. et al. (2004) Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol., 286, G515-G520.
44. Prokunina,L. et al. (2004) Regulatory SNPs in complex diseases: their identification and functional validation. Expert. Rev. Mol. Med., 6, 1-15.
45. Howell,W.M. et al. (2006) Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam. Cancer, 5, 143-149.
46. Gunter,M.J. et al. (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., 15 1126-1131.
47. Li,A. et al. (2001) Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res., 7, 3298-3304.
48. Adris,S. et al. (1999) IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T-cell mediated tumour rejection in the context of a systemic Th2 response. Gene Ther., 6, 1705-1712.
49. Stearns,M.E. et al. (2003) Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumour lines. Clin. Cancer Res. 9, 1191-1199.